B-1 immune cells can recognize all sorts of viruses, Yale researchers find. Mimicking them may enable a pan-virus treatment that can address many virus types.
No other vaccines are given at such a high frequency, but experts say there’s no reason to believe that the vaccines — and in particular, the mRNA vaccines from Pfizer and Moderna — aren’t effective.
The National Academy of Medicine (NAM) has announced the election of two Yale School of Medicine (YSM) faculty members as new NAM members. Erol Fikrig, MD, is Waldemar Von Zedtwitz Professor of Medicine (Infectious Diseases), professor of epidemiology (microbial diseases) and of microbial pathogenesis, and section chief for infectious disease in YSM’s Department of Internal Medicine. Haifan Lin, PhD, is Eugene Higgins Professor of Cell Biology; professor of genetics; of obstetrics, gynecology & reproductive sciences; and of dermatology; and director of the Yale Stem Cell Center. They are among 90 newly elected regular members of NAM, along with 10 international members.
In new research published in Nature Communications, Yale School of Public Health epidemiologist Dr. Sunil Parikh, MD, MPH, and colleagues from the University of Arkansas for Medical Sciences and Cameroon, present a new noninvasive test that could dramatically alter the global malaria testing landscape by providing reliable, safe, and sensitive testing to low- and middle-income countries that have been plagued by the deadly mosquito-borne disease.
Early in the COVID-19 pandemic, racial outcome disparities emerged. In the first year, for example, Black and Hispanic patients were far likelier to die than white patients were.
Yet a bright spot occurred at Yale. Not only was the mortality rate throughout Yale New Haven Health in the pandemic’s first two years lower than the national average, but also no race-based survival differences occurred among discharged patients.
Yale researchers and scientists in 14 other countries have established a new system of dengue lineages which, they say, will allow better tracking and improve vaccine development. They recently described the new system in a study published in the journal PLOS Biology.
Dr. Anthony Fauci’s recent diagnosis with a case of West Nile virus has brought renewed attention to the little-known illness that is the leading cause of mosquito-borne disease in the continental United States. Yale School of Public Health Associate Professor Nathan Grubaugh, an infectious disease epidemiologist, said the number of cases of West Nile virus nationally has stayed relatively stable over the past decade with about 1,000 to 3,000 cases per year.